Cargando…

Low MicroRNA-126 Levels in Right Ventricular Endomyocardial Biopsies Coincide With Cardiac Allograft Vasculopathy in Heart Transplant Patients

Endothelium-enriched microRNAs (miRs) are involved in the development of cardiac allograft vasculopathy (CAV). Recently, serum-derived miR-126-3p and -5p, known endothelial microRNAs with a crucial function in angiogenesis and re-endothelialization, provided additional predictive power for cardiac a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heggermont, Ward A., Delrue, Leen, Dierickx, Karen, Dierckx, Riet, Verstreken, Sofie, Goethals, Marc, Bartunek, Jozef, Vanderheyden, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	Heart Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213604/ https://www.ncbi.nlm.nih.gov/pubmed/32548243 http://dx.doi.org/10.1097/TXD.0000000000000995

Ejemplares similares

Hemodynamic Response to Acute Volume Load and Endomyocardial NO-synthase Gene Expression in Heart Transplant Recipients
por: Kobediona, Monika, et al.
Publicado: (2022)

Circulating SERPINA3 improves prognostic stratification in patients with a de novo or worsened heart failure
por: Delrue, Leen, et al.
Publicado: (2021)

T Cell and Antibody Response Following Double Dose of BNT162b2 mRNA Vaccine in SARS-CoV-2 Naïve Heart Transplant Recipients
por: Delrue, Leen, et al.
Publicado: (2022)

Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients
por: Nagumo, Sakura, et al.
Publicado: (2020)

Validation of Coronary Angiography-Derived Vessel Fractional Flow Reserve in Heart Transplant Patients with Suspected Graft Vasculopathy
por: Mileva, Niya, et al.
Publicado: (2021)

Utilizing longitudinal data in assessing all‐cause mortality in patients hospitalized with heart failure
por: Herman, Robert, et al.
Publicado: (2022)

Coronary Collateral Circulation: A New Predictor of Mortality in Heart Transplant Recipients With Allograft Vasculopathy
por: Civieri, Giovanni, et al.
Publicado: (2023)

Sex Related Differences in the Risk of Antibody-Mediated Rejection and Subsequent Allograft Vasculopathy Post-Heart Transplantation: A Single-Center Experience
por: Grupper, Avishay, et al.
Publicado: (2016)

Analysis of Fibrotic Plaques in Angiographic Manifest Cardiac Allograft Vasculopathy in Long-term Heart Transplanted Patients Using Optical Coherence Tomography
por: Orban, Madeleine, et al.
Publicado: (2021)

Recurrent Mild Acute Rejections and Donor-specific Antibodies as Risk Factors for Cardiac Allograft Vasculopathy in a National Pediatric Heart Transplant Cohort
por: Kaskinen, Anu K., et al.
Publicado: (2023)

Cardio–renal–metabolic syndrome: clinical features and dapagliflozin eligibility in a real‐world heart failure cohort
por: Beles, Monika, et al.
Publicado: (2023)

Detection of transthyretin amyloid cardiomyopathy by automated data extraction from electronic health records
por: Moya, Ana, et al.
Publicado: (2023)

Novel IVC Doraya Catheter Provides Congestion Relief in Patients With Acute Heart Failure
por: Zymliński, Robert, et al.
Publicado: (2022)

Serial Non-Invasive Myocardial Work Measurements for Patient Risk Stratification and Early Detection of Cancer Therapeutics-Related Cardiac Dysfunction in Breast Cancer Patients: A Single-Centre Observational Study
por: Moya, Ana, et al.
Publicado: (2023)

Microvesicular Steatosis and Severe Cardiac Allograft Dysfunction
por: Mai, Xingchen, et al.
Publicado: (2022)

Differential expression of epigenetic modifiers in early and late cardiotoxic heart failure reveals DNA methylation as a key regulator of cardiotoxicity
por: Robinson, Emma L., et al.
Publicado: (2023)

Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis
por: Skorić, Boško, et al.
Publicado: (2014)

Association of CD14(+) monocyte-derived progenitor cells with cardiac allograft vasculopathy
por: Salama, Mohamed, et al.
Publicado: (2011)

Safety, Feasibility of Controllable Decrease of Vena Cava Pressure by Doraya Catheter in Heart Failure
por: Zymliński, Robert, et al.
Publicado: (2023)

Biomarkers to Assess Right Heart Pressures in Recipients of a Heart Transplant: A Proof-of-Concept Study
por: Huang, Qi-Fang, et al.
Publicado: (2018)

Simultaneous Versus Sequential Heart-liver Transplantation: Ideal Strategies for Organ Allocation
por: Rucker, A. Justin, et al.
Publicado: (2018)

Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients
por: Cehic, Matthew G., et al.
Publicado: (2019)

Disseminated Intravascular Coagulation Following Heart Transplant in an HIV-infected Recipient: Case Report and Review of the Literature
por: Zhou, Xun, et al.
Publicado: (2019)

Impact of Heart Transplantation on the Recovery of Peripheral and Respiratory Muscle Mass and Strength in Patients With Chronic Heart Failure
por: Fernandes, Lenise C. B. C., et al.
Publicado: (2018)

Reversibility of Frailty After Bridge-to-Transplant Ventricular Assist Device Implantation or Heart Transplantation
por: Jha, Sunita R., et al.
Publicado: (2017)

Access to Heart Transplantation: A Proper Analysis of the Competing Risks of Death and Transplantation Is Required to Optimize Graft Allocation
por: Cantrelle, Christelle, et al.
Publicado: (2017)

Three-Dimensional Self-Navigated T2 Mapping for the Detection of Acute Cellular Rejection After Orthotopic Heart Transplantation
por: van Heeswijk, Ruud B., et al.
Publicado: (2017)

Circulating Donor Heart Exosome Profiling Enables Noninvasive Detection of Antibody-mediated Rejection
por: Hu, Robert W., et al.
Publicado: (2020)

Rejection-associated Mitochondrial Impairment After Heart Transplantation
por: Romero, Erick, et al.
Publicado: (2020)

Heart Transplantation From Hepatitis C–Positive Donors in the Era of Direct Acting Antiviral Therapy: A Comprehensive Literature Review
por: Bruno, Schnegg, et al.
Publicado: (2019)

De Novo Belatacept in a Kidney-After-Heart Transplant Recipient
por: Schenk, Austin D., et al.
Publicado: (2019)

Bone Mineral Density in Relation to Chronic Kidney Disease After Heart Transplantation: A Retrospective Single-center Study at Skåne University Hospital in Lund 1988–2016
por: Löfdahl, Eveline, et al.
Publicado: (2020)

Impact of New UNOS Allocation Criteria on Heart Transplant Practices and Outcomes
por: Liu, Jason, et al.
Publicado: (2020)

Ex Situ Perfusion of Hearts Donated After Euthanasia: A Promising Contribution to Heart Transplantation
por: van Suylen, Vincent, et al.
Publicado: (2021)

Patient and Caregiver Health-related Quality of Life and Caregiver Burden While Awaiting Heart Transplantation: Findings From the Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support (SUSTAIN-IT) Study
por: Grady, Kathleen L., et al.
Publicado: (2021)

Differences in Heart Graft Survival by Recipient Sex
por: Foster, Bethany J., et al.
Publicado: (2021)

Trends in Heart and Lung Transplantation in the United States Across the COVID-19 Pandemic
por: Hallett, Andrew, et al.
Publicado: (2021)

Pulmonary Function Testing Pre–heart Transplant Predicts Posttransplant Survival
por: Lundgren, Scott W., et al.
Publicado: (2021)

The Interaction of Amiodarone and Continuous-flow Left Ventricular Assist Device Use in Risk of Severe Primary Graft Dysfunction Following Heart Transplantation
por: Chinnadurai, Thiru, et al.
Publicado: (2022)

Clinical Outcomes of Perioperative Desensitization in Heart Transplant Recipients
por: Plazak, Michael E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9c17nb6ksv3bq7rqrh2359rqur